60889-32-9 Usage
Description
Hexahydro-1H-furo[3,4-c]pyrrole is a chemical compound that belongs to the class of organic compounds known as furanopyrroles. These are heterocyclic compounds containing a furan ring fused to a pyrrole ring. Hexahydro-1H-furo[3,4-c]pyrrole is a relatively neutral molecule, based on its structure. Its exact properties in terms of behavior in specific conditions or its potential uses are currently not very well characterized in the literature. This could possibly be due to its rarity or difficulty in extraction or production.
Uses
Hexahydro-1H-furo[3,4-c]pyrrole is used as a chemical compound in the field of organic chemistry for its potential applications in scientific, medical, and industrial domains. However, due to the limited information available in the literature, its specific uses and applications are not well defined at this time. Further research is required to better understand and explore its applications in these areas.
Check Digit Verification of cas no
The CAS Registry Mumber 60889-32-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,8,8 and 9 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 60889-32:
(7*6)+(6*0)+(5*8)+(4*8)+(3*9)+(2*3)+(1*2)=149
149 % 10 = 9
So 60889-32-9 is a valid CAS Registry Number.
60889-32-9Relevant articles and documents
2-PHENYL-5-HETEROCYCLYL-TETRAHYDRO-2H-PYRAN-3-AMINE COMPOUNDS FOR USE IN THE TREATMENT OF DIABETES AND ITS ASSOCIATED DISORDERS
-
Page/Page column 27; 28; 29, (2014/05/07)
The present invention relates to novel compounds of the general formula (I) their tautomeric forms, their enantiomers, their diastereoisomers, their pharmaceutically accepted salts, or pro-drugs thereof, which are useful for the treatment or prevention of diabetes mellitus (DM), obesity and other metabolic disorders. The invention also relates to process for the manufacture of said compounds, and pharmaceutical compositions containing them and their use.
AMINOQUINAZOLINE DERIVATIVES AND THEIR SALTS AND METHODS OF USE
-
Paragraph 00293, (2013/06/05)
The present invention relates to the field of medicine. Provided herein are aminoquinazoline derivatives, their salts and pharmaceutical formulations useful in modulating the protein tyrosine kinase activity, and in modulating inter-and/or intra-cellular signaling. Also provided herein are pharmaceutically acceptable compositions comprising the aminoquinazoline compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.